Literature DB >> 24409494

Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function.

Elizabeth C Goode, Richard C Warburton, William T H Gelson, Alastair J M Watson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24409494     DOI： 10.1053/j.gastro.2013.10.031

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  4 in total

1.  Monocyte-derived dendritic cells from cirrhotic patients retain similar capacity for maturation/activation and antigen presentation as those from healthy subjects.

Authors:  Shiroh Tanoue; Li-Yuan Chang; Yonghai Li; David E Kaplan
Journal:  Cell Immunol       Date:  2015-02-25       Impact factor: 4.868

Review 2.  Functional macrophages and gastrointestinal disorders.

Authors:  Yue-Hong Liu; Yue Ding; Chen-Chen Gao; Li-Sheng Li; Yue-Xiu Wang; Jing-Dong Xu
Journal:  World J Gastroenterol       Date:  2018-03-21       Impact factor: 5.742

3.  5-Methoxyl Aesculetin Abrogates Lipopolysaccharide-Induced Inflammation by Suppressing MAPK and AP-1 Pathways in RAW 264.7 Cells.

Authors:  Lei Wu; Xueqin Li; Haifeng Wu; Wei Long; Xiaojian Jiang; Ting Shen; Qian Qiang; Chuanling Si; Xinfeng Wang; Yunyao Jiang; Weicheng Hu
Journal:  Int J Mol Sci       Date:  2016-03-01       Impact factor: 5.923

Review 4.  Biological characteristics of IL-6 and related intestinal diseases.

Authors:  Yuexin Guo; Boya Wang; Tiantian Wang; Lei Gao; Ze-Jun Yang; Fei-Fei Wang; Hong-Wei Shang; Rongxuan Hua; Jing-Dong Xu
Journal:  Int J Biol Sci       Date:  2021-01-01       Impact factor: 6.580
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.